TherapeuticsMD Files 2024 Annual Report
Ticker: TXMD · Form: 10-K · Filed: Mar 27, 2025 · CIK: 25743
Sentiment: neutral
Topics: 10-K, annual-report, pharmaceuticals
TL;DR
TherapeuticsMD filed its 2024 10-K. Check financials.
AI Summary
TherapeuticsMD, Inc. filed its annual report for the fiscal year ended December 31, 2024. The company, incorporated in Nevada, operates in the pharmaceutical preparations sector. Its principal executive offices are located at 951 Yamato Road, Suite 220, Boca Raton, Florida. The filing was made on March 27, 2025.
Why It Matters
This 10-K filing provides a comprehensive overview of TherapeuticsMD's financial performance and business operations for the fiscal year 2024, crucial for investors to assess the company's health and future prospects.
Risk Assessment
Risk Level: medium — This is a standard annual report filing and does not inherently contain new risk-triggering information.
Key Numbers
- 2024 — Fiscal Year End (The period covered by the annual report.)
- 001-00100 — Commission File Number (Unique identifier for the company's SEC filings.)
- 87-0233535 — EIN (Employer Identification Number.)
Key Players & Entities
- TherapeuticsMD, Inc. (company) — Registrant
- 2024 (date) — Fiscal year end
- December 31 (date) — Fiscal year end
- Nevada (location) — State of incorporation
- 951 Yamato Road, Suite 220, Boca Raton, Florida 33431 (address) — Principal executive offices
- 20250327 (date) — Filing date
FAQ
What is the primary business of TherapeuticsMD, Inc.?
TherapeuticsMD, Inc. operates in the Pharmaceutical Preparations sector, as indicated by its Standard Industrial Classification code [2834].
When was the company incorporated?
TherapeuticsMD, Inc. was incorporated in Nevada.
What is the address of TherapeuticsMD's principal executive offices?
The principal executive offices are located at 951 Yamato Road, Suite 220, Boca Raton, Florida 33431.
What is the filing date of this 10-K report?
This 10-K report was filed on March 27, 2025.
What fiscal year does this 10-K report cover?
This 10-K report covers the fiscal year ended December 31, 2024.
Filing Details
This Form 10-K (Form 10-K) was filed with the SEC on March 27, 2025 regarding TherapeuticsMD, Inc. (TXMD).